Application Note
For ELISA: Use at an assay dependent concentration. For RIA: Use at an assay dependent concentration. Optimal dilutions/concentrations should be determined by the end user.
Product Note
Recognises p35/40 heterodimer and p40. Used against CCHO and Baculovirus derived recombinant IL-12. Reacts with stimulated and unstimulated monocytes.
Form
Liquid
Buffer
PBS
Preservative
No preservative
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
0.7 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
Recombinant human interleukin-12 produced in Baculovirus.
Purification
Protein A affinity purified
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
Synonyms
Subunit P40 , Natural Killer Cell Stimulatory Factor2 , Natural Killer Cell Stimulatory Factor 2 , Interleukin 12B , 40 kD Subunit , Cytotoxic lymphocyte maturation factor 40 kDa subunit , T cell stimulating factor , Cytotoxic lymphocyte maturation factor40 kDa subunit , CLMF2 , Interleukin12B , TSF , Cytotoxic Lymphocyte Maturation Factor 2 , IL12 , Cytotoxic Lymphocyte Maturation Factor2 , HGNC:5970 , IL1 , NKSF2 , CLMF , IL-12B , NKSF , IL 12B , IL12B
Cellular Localization
Secreted
Background
IL12 is a heterodimeric cytokine comprised of p35 and p40 subunits. IL12 plays a central role in mediating cell mediated immunity, promoting differentiation of CD4+ T cells to the Th1 subset and of CD8+ T cells into mature cytotoxic T lymphocytes (CTLs). IL12 is a potent stimulator of NK cells. IL12 therapy has been suggested as a method of enhancing cytocidal anti tumour immune responses.
Research Area